We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

GlaxoSmithKline (Ireland) Ltd

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 495 5000
Fax: +353 1 4955225
Medical Information Direct Line: 1 800 244 255
Medical Information Facsimile: +353 1 495 5225
Patient Information Leaflet last updated on medicines.ie: 11/07/2017
PIL AVAMYS 27.5 micrograms/spray nasal spray suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 11/07/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - use in children and adolescents
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 07/06/2017 and displayed until 11/07/2017
Reasons for adding or updating:
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
Updated on 24/12/2015 and displayed until 07/06/2017
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to further information section
  • Change to date of revision
Updated on 03/11/2015 and displayed until 24/12/2015
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 09/01/2014 and displayed until 03/11/2015
Reasons for adding or updating:
  • Change to side-effects
Updated on 13/02/2013 and displayed until 09/01/2014
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 19/09/2012 and displayed until 13/02/2013
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 31/05/2012 and displayed until 19/09/2012
Reasons for adding or updating:
  • Change to side-effects
Updated on 08/04/2010 and displayed until 31/05/2012
Reasons for adding or updating:
  • Change of manufacturer
  • Change to storage instructions
  • Change to side-effects
Updated on 31/03/2010 and displayed until 08/04/2010
Reasons for adding or updating:
  • Change of manufacturer
  • Change to storage instructions
  • Change to side-effects
Updated on 01/07/2009 and displayed until 31/03/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 05/03/2008 and displayed until 01/07/2009
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Fluticasone furoate